Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

迈通诺 - NMPA Drug Approval Details

Approvals/NMPA/Propiverine Hydrochloride Modified Release Capsules

Approved

化学药品

Propiverine Hydrochloride Modified Release Capsules

Apogepha Arzneimittel GmbH🇨🇳 National Medical Products Administration

Approval Date: Apr 13, 2020
Approval ID: 7MazXcOK79p
Company: Apogepha Arzneimittel GmbH
Type: 化学药品

Approval Details

Approval Id: 7MazXcOK79p
Approval Number: H20170173
Generic Name: 盐酸丙哌维林缓释胶囊
Generic Name En: Propiverine Hydrochloride Modified Release Capsules
Trade Name: 迈通诺
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 30mg
Reg Date: 2020-04-13
Expired Date: 2024-11-14
Company Name: Apogepha Arzneimittel GmbH
Company Address: Kyffhauserstrasse 27, D-01309 Dresden
Production Company Name: Losan Pharma GmbH
Production Company Address: Otto-Hahn-Strasse 13 79395 Neuenburg, Germany
Company Detail Path: /organization/apogepha-arzneimittel-gmbh
Production Company Detail Path: /organization/losan-pharma-gmbh

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 13, 2020

Approval ID

7MazXcOK79p

Type

化学药品

Back to NMPA Approvals